Live Breaking News & Updates on Riccardo perfetti

Stay informed with the latest breaking news from Riccardo perfetti on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Riccardo perfetti and stay connected to the pulse of your community

Applied Therapeutics (NASDAQ:APLT) Shares Down 3.7%

Shares of Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) were down 3.7% during mid-day trading on Tuesday . The stock traded as low as $5.45 and last traded at $5.45. Approximately 133,499 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 2,099,365 shares. The stock had previously […]

Canada , United-states , Riccardo-perfetti , Leerink-partnrs , Leslied-funtleyder , Vontobel-holding-ltd , Goldman-sachs-group-inc , Therapeutics-inc , Therapeutics-company-profile , Commonwealth-equity-services , Nasdaq , Royal-bank

Applied Therapeutics (NASDAQ:APLT) Shares Down 3.7%

Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report)’s share price was down 3.7% during mid-day trading on Tuesday . The company traded as low as $5.45 and last traded at $5.45. Approximately 133,499 shares traded hands during trading, a decline of 94% from the average daily volume of 2,099,365 shares. The stock had previously closed […]

Canada , United-states , Leerink-partnrs , Leslied-funtleyder , Riccardo-perfetti , Royal-bank , Nasdaq , Citigroup , Capital-management , Armistice-capital , Securities-exchange-commission , Worth-venture-partners

Applied Therapeutics (APLT) to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

Applied Therapeutics (APLT) to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Atlanta , Georgia , United-states , Javed-butler , Gregoryd-lewis , Riccardo-perfetti , Faiez-zannad , Thomash-marwick , Julio-rosenstock , Nasriene-ibrahim , Justina-ezekowitz , Wh-wilson-tang

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Atlanta , Georgia , United-states , Maeve-conneighton , Nasriene-ibrahim , Jamesl-januzzi-jr , Thomash-marwick , Gregoryd-lewis , Riccardo-perfetti , Justina-ezekowitz , Faiez-zannad , Advanz-pharma

Short Interest in Applied Therapeutics, Inc. (NASDAQ:APLT) Decreases By 12.5%

Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 3,790,000 shares, a decline of 12.5% from the February 29th total of 4,330,000 shares. Based on an average daily volume of 2,120,000 shares, the short-interest ratio […]

United-states , Blackrock , Nova-scotia , Canada , Leerink-partnrs , Riccardo-perfetti , Leslied-funtleyder , Nasdaq , Securities-exchange-commission , Renaissance-technologies , Citigroup , Blackrock-inc

Applied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.80

Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report)’s stock price gapped down before the market opened on Monday . The stock had previously closed at $6.80, but opened at $6.00. Applied Therapeutics shares last traded at $6.31, with a volume of 687,581 shares trading hands. Analyst Ratings Changes Several equities research analysts recently commented on […]

Canada , United-states , Leerink-partnrs , Leslied-funtleyder , Riccardo-perfetti , Royal-bank , Northern-trust-corp , Nasdaq , Therapeutics-inc , Commonwealth-equity-services , Securities-exchange-commission , Citigroup

Applied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.75

Applied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.75
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Leslied-funtleyder , Riccardo-perfetti , Leerink-partnrs , Vr-adviser , Citigroup , Therapeutics-inc , Armistice-capital , Franklin-resources-inc , Nasdaq , Applied-therapeutics , Get-free-report

Functional Improvement Seen With Govorestat in SORD Deficiency Trial

The phase 3 double-blind, placebo-controlled INSPIRE trial included 56 patients aged 16 to 55 years with genetically-confirmed SORD deficiency

Riccardo-perfetti , Health-index , Chief-medical-officer ,

Applied Therapeutics (APLT) Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in SORD Deficiency

Applied Therapeutics (APLT) Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in SORD Deficiency
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Riccardo-perfetti , Shoshana-shendelman , Health-index , University-of-iowa-medical-center , Therapeutics-inc , Drug-administration , Nasdaq , Applied-therapeutics , Sorbitol-dehydrogenase , Aldose-reductase-inhibitor , New-drug-application , Analysis-results

AT-001 Fails to Achieve Significance for Primary Endpoint in ARISE-HF

Applied Therapeutics announced topline results from ARISE-HF on January 04, 2023 and plans to present full results at an upcoming medical conference.

United-states , America , James-januzzi , Riccardo-perfetti , Institute-james-januzzi , Hutton-family-professor , Massachusetts-general , Applied-therapeutics , North-america , Chief-medical-officer ,